This footage was filmed and produced 12 November 2022.

Chinese patent medicine Reyanning Mixture (RYN) is displayed by a citizen in Yichang, Hubei province, China, Nov 12, 2022. According to China Journal of Traditional Chinese Medicine: Recently, the research team of Professor Fang Bangjiang from Shanghai University of Traditional Chinese Medicine published a paper in the internationally renowned medical journal Phytomedicine titled "The effect of Reyanning Mixture Combined Standard Treatment on asymptomatic or mildly infected patients with COVID-19: A prospective, open-label, randomized controlled trial confirmed that Reyanning mixture (RYN) can promote negative nucleic acid conversion in patients with asymptomatic and mild ormicron infection on the basis of standard treatment, providing a new evidence-based basis for the clinical efficacy of traditional Chinese medicine in the treatment of COVID-19.